Yesterday, Ian Town (Chief Science Advisor, Ministry of Health) visited Middlemore Clinical Trials and presented at Middlemore Hospital’s Grand Round on the New Zealand Health Research Strategy 2017 – 2027.
The Cath Lab; Coronary Care Unit (CCU) and Middlemore Clinical Trials (MMCT) have been involved in a novel stent trial this year, recruiting 10 trial participants to-date (target of 7 participants) making Middlemore Hospital the highest recruiting site for the trial. Dr Douglas Scott (Primary Investigator) and Kavita Gounder (Primary Research Nurse – MMCT) have therefore been invited by the Trial Sponsor (Elixir Medical Corporation) to attend the TCT2019 Conference.
As of September 2019 MMCT has a new current trials feature available on the MMCT website. This will allow GP's and specialists to direct refer a patient to a trial with just a few simple clicks, after which MMCT staff will contact the patient for trial vetting and acceptance.